Full-Time

Finance Project/Program Manager

Confirmed live in the last 24 hours

HeartFlow

HeartFlow

501-1,000 employees

Non-invasive cardiac testing technology provider

Compensation Overview

$100k - $120k/yr

+ Cash Bonus + Stock Options

Senior

Remote in USA

Candidates must be based in the United States and willing to work in PST time zone.

Category
Project Management
Business & Strategy
Required Skills
NetSuite
Data Analysis
Excel/Numbers/Sheets
Requirements
  • Bachelor's degree in Finance, Accounting, Business Administration, or a related field
  • Minimum of 5+ years of experience in pricing, rebate management, contract administration, or a related role
  • Strong understanding of contract terms and revenue recognition principles
  • Proficiency in ERP systems, preferably NetSuite
  • Advanced Excel skills, including experience with complex formulas and data analysis
  • Excellent analytical, problem-solving, and communication skills
  • Strong attention to detail and accuracy
  • Ability to work independently and collaboratively in a fast-paced environment
Responsibilities
  • Thoroughly review and analyze customer contracts to understand product pricing, rebate structures, and payment terms
  • Translate complex contract terms into actionable data within the ERP system
  • Maintain a comprehensive database of contract details, including effective dates, pricing schedules, and rebate eligibility
  • Manage and maintain customer pricing, rebate programs, and contract data within NetSuite
  • Ensure accurate data entry and integrity of information related to customer agreements
  • Develop and implement processes for efficient data management and reporting
  • Collaborate with IT to implement ERP changes and enhancements to support pricing, rebate, and reporting needs
  • Verify the accuracy of customer invoices and credits based on contract terms and rebate programs
  • Ensure timely and accurate application of customer credits
  • Resolve discrepancies and address customer billing inquiries related to pricing and rebates
  • Work closely with the Customer Success, Contracts, and Commercial Operations teams to understand contract pipelines, effective dates, and customer needs
  • Communicate contract and pricing information effectively to relevant stakeholders
  • Provide support and guidance to other departments on pricing and rebate-related matters
  • Generate and analyze reports on customer pricing, rebates, and revenue trends
  • Identify and investigate variances in pricing and rebate calculations
  • Develop and maintain key performance indicators (KPIs) related to pricing and rebate management
  • Assist in the forecasting and budgeting processes related to customer revenue and rebates
  • Identify and implement process improvements to enhance the efficiency and accuracy of pricing and rebate management
  • Document and maintain standard operating procedures (SOPs) for pricing and rebate processes
  • Ensure compliance with internal controls and regulatory requirements related to pricing and billing
Desired Qualifications
  • Experience in the medical device or healthcare industry is a plus
  • Experience working with IT teams to implement system changes

HeartFlow provides a non-invasive cardiac test that helps visualize a patient's coronary arteries, aiding physicians in diagnosing and treating heart disease. The technology allows for detailed analysis through various components, including FFRCT Analysis, RoadMap Analysis, Plaque Analysis, and HeartFlow Planner. This approach eliminates the need for invasive procedures, making cardiovascular care safer and more efficient for both patients and healthcare providers. HeartFlow's products have received FDA clearance and are available in the United States, the United Kingdom, Japan, and Canada. Unlike many competitors, HeartFlow focuses on providing a comprehensive analysis that enhances treatment planning while reducing risks and costs associated with traditional diagnostic methods. The company's goal is to improve cardiovascular care by offering advanced, non-invasive solutions that support better health outcomes.

Company Size

501-1,000

Company Stage

Debt Financing

Total Funding

$1B

Headquarters

Redwood City, California

Founded

2010

Simplify Jobs

Simplify's Take

What believers are saying

  • HeartFlow's technology aligns with the growing trend of AI adoption in healthcare.
  • The global non-invasive cardiac imaging market is projected to grow significantly, benefiting HeartFlow.
  • Updated AHA guidelines emphasize non-invasive testing, increasing demand for HeartFlow's FFRCT Analysis.

What critics are saying

  • Emerging AI-driven cardiovascular tools could threaten HeartFlow's market share.
  • HeartFlow's reliance on continuous funding rounds indicates potential financial instability.
  • New regulatory requirements for AI in healthcare could necessitate costly adjustments for HeartFlow.

What makes HeartFlow unique

  • HeartFlow offers a unique AI-driven non-invasive cardiac test for coronary artery visualization.
  • The company's technology integrates over two decades of scientific evidence with AI advancements.
  • HeartFlow is the only provider offering both anatomical and physiological coronary artery visualization.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Stock Options

401(k) Company Match

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

-2%
Intelligence360
Apr 22nd, 2025
HeartFlow Raises $50M in Debt Financing

HeartFlow has filed a notice for an exempt offering of securities to raise $50 million in new debt financing. This filing with the U.S. Securities and Exchange Commission is required under federal securities law for companies selling securities without registration under the Securities Act of 1933, specifically under Rule 504 or 506 of Regulation D or Section 4(a)(5). The notice must be filed within 15 days after the first sale of securities in the offering.

Benzinga
Mar 26th, 2025
Heartflow Secures $98M in Funding

Heartflow, Inc. announced a $98 million convertible notes financing led by its parent company, Heartflow Holding, Inc. New and existing investors, including Fidelity Management, Janus Henderson, and Bain Capital, participated. The funds will support R&D to advance Heartflow's AI-driven coronary care platform. Heartflow's technology, recognized for innovation, aims to improve CAD diagnosis and management. The platform has been used for over 400,000 patients globally.

National Law Review
Mar 26th, 2025
Heartflow Closes $98 Million Convertible Notes Financing

Heartflow was recently named one of Fast Company's Most Innovative Companies in Medical Devices for 2025 and won the Innovation in Cardiac Imaging award at the Global Cardiovascular Awards 2025.

Hit Consultant
Jan 22nd, 2025
Heartflow And Boone Heart Institute Launch Gamefilm Registry To Study Heart Health In Retired Nfl Players

HeartFlow and Boone Heart Institute Launch GAMEFILM Registry to Study Heart Health in Retired NFL Players. by Fred Pennic 01/22/2025 Leave a Comment. What You Should Know: – HeartFlow, a global leader in AI-driven heart care solutions, and Boone Heart Institute, a renowned cardiovascular care provider in Denver, today announced the launch of the GAMEFILM Registry. – GAMEFILM Registry will utilize advanced imaging and AI technology to assess and better understand coronary artery disease (CAD) risk in retired National Football League (NFL) players.Understanding the Unique Cardiovascular Risks of Retired NFL PlayersCardiovascular disease remains the leading cause of death globally. Despite advancements in diagnostics, many heart attacks and strokes occur in individuals without prior symptoms. Early identification of high-risk individuals is critical for effective prevention and treatment. Retired NFL players often face unique cardiovascular health challenges due to the intense physical demands of their careers

GlobeNewswire
Oct 18th, 2024
HeartFlow Announces New Category I CPT Code from the American Medical Association for AI-Enabled Plaque Analysis to Assess Risk for Coronary Artery Disease

HeartFlow announces new Category I CPT code from the American Medical Association for ai-enabled Plaque Analysis to assess risk for coronary artery disease.